Innovations in Stem Cell-based Implants, ALS Treatment, CRISPR, and Personalized Cell Vaccines

Share this:
Published: 27 Apr 2018

This edition of the Genetic Technology TOE depicts trends across stem cell-based implants, ALS treatment, gene editing, and personalized cell vaccines. The clinical trials scenario for the treatment of cancer with vaccines is also depicted The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Stem cell-based implants, amyotrophic lateral sclerosis, ALS, motor neurone disease, MND, Lou Gehrig's disease, gene editing, CRISPR, cancer vaccines, macular regeneration, personalized cell vaccine, ovarian cancer



Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..